Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:287-288 (9 February), doi:10.1136/bmj.39409.633576.BE
The European Commission needs to promote access to the data whose collection it has financed
| The first 150 words of the full text of this article appear below. |
The year 2007 marks the beginning of the European Commissions seventh framework programme for research and technological development, its main vehicle for funding research over the next seven years. It is more ambitious than its antecedent—the sixth framework programme—with a large increase in funding (63%) and the creation of a European Research Council. Health research has been boosted, having been allocated
6bn (£4.3bn; $9bn) of the overall budget of
50.5bn. Yet the seventh framework programme has done little to promote access to the data whose collection it will finance.
This lack of concrete policies on access to data in Europe contrasts with the proliferation of wider international initiatives over recent years. Such initiatives have been particularly successful in genomics and proteomics,1 and more recently in the field of chemistry,2 but they have also shown promise in health. Examples in the United Kingdom include the policies of the Medical Research Council
Philipa Mladovsky, research officer1, Elias Mossialos, professor of health policy and director of LSE Health1, Martin McKee, professor of European public health2
1 European Observatory on Health Systems and Policies, London School of Economics and Political Science, LSE Health, London WC2A 2AE, 2 European Observatory on Health Systems and Policies, London School of Hygiene and Tropical Medicine, London WC1E 7HT
p.mladovsky@lse.ac.uk
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.